# Masashi Mizuno

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/masashi-mizuno/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,941 |
| Field | Dialysis and Renal Disease Management |
| h-index | 43 |
| i10-index | 132 |
| Last Known Institution | Nagoya University |
| OpenAlex ID | https://openalex.org/A5040530753 |
| ORCID iD | 0000-0003-3235-6880 |
| Works | 301 |

## Researcher papers

- [Scar-Associated Macrophages Are a Major Source of Hepatic Matrix Metalloproteinase-13 and Facilitate the Resolution of Murine Hepatic Fibrosis](https://scholariq.org/papers/scar-associated-macrophages-are-a-major-source-of-hepatic-matrix/)
- [Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts](https://scholariq.org/papers/empagliflozin-normalizes-the-size-and-number-of-mitochondria-and-prevents/)
- [CD46 Plays a Key Role in Tailoring Innate Immune Recognition of Apoptotic and Necrotic Cells](https://scholariq.org/papers/cd46-plays-a-key-role-in-tailoring-innate-immune-recognition-of-apoptotic-and/)
- [Hip Fracture Prevention Trial Using Hip Protectors in Japanese Nursing Homes](https://scholariq.org/papers/hip-fracture-prevention-trial-using-hip-protectors-in-japanese-nursing-homes/)
- [Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats](https://scholariq.org/papers/empagliflozin-an-sglt2-inhibitor-reduced-the-mortality-rate-after-acute/)
- [Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial](https://scholariq.org/papers/impact-of-primary-kidney-disease-on-the-effects-of-empagliflozin-in-patients/)
- [Lymphatic vessels develop during tubulointerstitial fibrosis](https://scholariq.org/papers/lymphatic-vessels-develop-during-tubulointerstitial-fibrosis/)
- [The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice](https://scholariq.org/papers/the-membrane-attack-pathway-of-complement-drives-pathology-in-passively-induced/)
- [Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan](https://scholariq.org/papers/peritonitis-is-still-an-important-factor-for-withdrawal-from-peritoneal-dialysis/)
- [Association of the C–509→T polymorphism, alone or in combination with the T869→C polymorphism, of the transforming growth factor-β1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women](https://scholariq.org/papers/association-of-the-c-509-t-polymorphism-alone-or-in-combination-with-the-t869-c/)
- [Investigation on the benefits of mycophenolate mofetil and therapeutic drug monitoring in the treatment of Japanese patients with lupus nephritis](https://scholariq.org/papers/investigation-on-the-benefits-of-mycophenolate-mofetil-and-therapeutic-drug/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)

## Researcher university

- [Nagoya University](https://scholariq.org/institutions/nagoya-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.